1-7 of 7
David R. Stover
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1726: Preclinical evaluation of a novel tumor selectively targeted and activated immunocytokine platform

Kham R. Trinh, Alex Vasuthaswat, George Ayoub, Sherie L. Morrison, David R. Stover
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1726.
https://doi.org/10.1158/1538-7445.AM2021-1726
Published: 01 July 2021
View articletitled, Abstract 1726: Preclinical evaluation of a novel tumor selectively targeted and activated immunocytokine platform
Journal Articles

Abstract 1581: Nammisomes: Preclinical validation of a platform for selective and synchronized delivery of novel immunotherapy prodrug combinations to tumors

David R. Stover, Dhruba Bharali, Tahmineh Safaie, Bruce A. Hay, Rajesh K. Sharma, Scott Ayers
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1581.
https://doi.org/10.1158/1538-7445.AM2021-1581
Published: 01 July 2021
View articletitled, Abstract 1581: Nammisomes: Preclinical validation of a platform for selective and synchronized delivery of novel immunotherapy prodrug combinations to tumors
Journal Articles

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates

Hui Zhao, John Atkinson, Sara Gulesserian, Zhilan Zeng, Jenny Nater, Jimmy Ou, Peng Yang, Karen Morrison, Jeffrey Coleman, Faisal Malik, Pia Challita-Eid, Sher Karki, Hector Aviña, René Hubert, Linnette Capo, Josh Snyder, Sung-Ju Moon, Roland Luethy, Brian A. Mendelsohn, David R. Stover, Fernando Doñate
Journal: Cancer Research
Cancer Res (2018) 78 (8): 2115–2126.
https://doi.org/10.1158/0008-5472.CAN-17-3202
Published: 12 April 2018
View articletitled, Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates
Open the PDF for Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates in another window
Includes: Supplementary data
Journal Articles

Abstract 3853: Potential mechanisms for thrombocytopenia and neutropenia induced by antibody-drug conjugates

Hui Zhao, Sara Gulesserian, Sathish K. Ganesan, Zhilan Zeng, Jimmy Ou, Veronica Robles, Josh Snyder, David R. Stover, Fernando Donate
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3853.
https://doi.org/10.1158/1538-7445.AM2016-3853
Published: 15 July 2016
View articletitled, Abstract 3853: Potential mechanisms for thrombocytopenia and neutropenia induced by antibody-drug conjugates
Journal Articles

Abstract 574: AGS62P1, a novel site-specific antibody drug conjugate targeting FLT3 exhibits potent anti-tumor activity regardless of FLT3 kinase activation status

Nandini Rudra-Ganguly, Pia M. Challita-Eid, Christine Lowe, Mike Mattie, Sung-Ju Moon, Brian A. Mendelsohn, Monica Leavitt, Cyrus Virata, Alla Verlinsky, Linnette Capo, Mi Sook Chang, Deanna L. Russell, Baljinder Randhawa, Gao Liu, René Hubert, Mary Brodey, Hector Aviña, Chunying Zhang, Joseph D. Abad, Banmeet Anand, Sher Karki, Zili An, Roland Luethy, Fernando Doñate, Daniel S. Pereira, Kendall Morrison, Ingrid B.J. Joseph, David R. Stover
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 574.
https://doi.org/10.1158/1538-7445.AM2016-574
Published: 15 July 2016
View articletitled, Abstract 574: AGS62P1, a novel site-specific antibody drug conjugate targeting FLT3 exhibits potent anti-tumor activity regardless of FLT3 kinase activation status
Journal Articles

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang, Zili An, Karen Morrison, Yuriy Shostak, Arthur Raitano, Rossana Nadell, Wendy Liu, Dawn Ratay Lortie, Linnette Capo, Alla Verlinsky, Monica Leavitt, Faisal Malik, Hector Aviña, Claudia I. Guevara, Nick Dinh, Sher Karki, Banmeet S. Anand, Daniel S. Pereira, Ingrid B.J. Joseph, Fernando Doñate, Kendall Morrison, David R. Stover
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (10): 3003–3013.
https://doi.org/10.1158/0008-5472.CAN-15-1313
Published: 12 May 2016
View articletitled, Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Open the PDF for Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models in another window
Includes: Supplementary data
Journal Articles

Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy

Nandini Rudra-Ganguly, Christine Lowe, Mukta Shiwalkar, Claudia I. Guevara, Christopher Kemball, Min Michelle Wu, Cyrus Virata, Alla Verlinsky, Ssucheng J Hsu, Michael Mattie, William Yeh, Peng Yang, Sung-Ju Moon, Ingrid Joseph, David R. Stover, Daniel S. Pereira, Dowdy Jacksosn
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1976.
https://doi.org/10.1158/1538-7445.AM2014-1976
Published: 01 October 2014
View articletitled, Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy